Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DBV Technologies S.A. - American Depositary Shares (NQ:DBVT)

21.00 -0.52 (-2.42%)
Streaming Delayed Price Updated: 3:12 PM EST, Feb 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 271,681
Open 22.02
Bid (Size) 20.60 (100)
Ask (Size) 20.80 (100)
Prev. Close 21.52
Today's Range 20.49 - 22.11
52wk Range 3.820 - 26.18
Shares Outstanding 55,096,537
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit
From DBV Technologies S.A.
Via GlobeNewswire

Performance

YTD
+10.2%
+10.2%
1 Month
-14.1%
-14.1%
3 Month
+60.4%
+60.4%
6 Month
+121.0%
+121.0%
1 Year
+404.2%
+404.2%

More News

Read More
News headline image
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of January 31, 2026
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
GSK Challenges Xolair Dominance with $2.2 Billion Acquisition of RAPT Therapeutics
Via MarketMinute
Topics Intellectual Property
News headline image
DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Which stocks are moving before the opening bell on Monday? ↗
Via Chartmill
News headline image
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
News headline image
These stocks are gapping in today's session ↗
Via Chartmill
News headline image
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
DBV Technologies Stock Soars 63% After Hours As Strong Results For Peanut Allergy Patch Clears Path For FDA Filing ↗
Via Stocktwits
News headline image
DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
These stocks have an unusual volume in today's session ↗
Via Chartmill
News headline image
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of November 30, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
RFK Jr Rejects Early Exposure Theory On Rising Peanut Allergies, Says Aluminum-Based Vaccines Are The Reason ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
Why LightPath Technologies Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting
From DBV Technologies S.A.
Via GlobeNewswire

Frequently Asked Questions

Is DBV Technologies S.A. - American Depositary Shares publicly traded?
Yes, DBV Technologies S.A. - American Depositary Shares is publicly traded.
What exchange does DBV Technologies S.A. - American Depositary Shares trade on?
DBV Technologies S.A. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for DBV Technologies S.A. - American Depositary Shares?
The ticker symbol for DBV Technologies S.A. - American Depositary Shares is DBVT on the Nasdaq Stock Market
What is the current price of DBV Technologies S.A. - American Depositary Shares?
The current price of DBV Technologies S.A. - American Depositary Shares is 21.00
When was DBV Technologies S.A. - American Depositary Shares last traded?
The last trade of DBV Technologies S.A. - American Depositary Shares was at 02/27/26 03:12 PM ET
What is the market capitalization of DBV Technologies S.A. - American Depositary Shares?
The market capitalization of DBV Technologies S.A. - American Depositary Shares is 1.16B
How many shares of DBV Technologies S.A. - American Depositary Shares are outstanding?
DBV Technologies S.A. - American Depositary Shares has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.